British American Tobacco Plc is introducing a vaping device in the U.K. that delivers nicotine more efficiently, the latest salvo in a battle to attract smokers to cigarette alternatives amid ever tougher regulations on smoking. BAT is debuting the new
In testing that included over 1,200 children, researchers found that up to 15 percent of them had levels of cotinine, a byproduct of the body’s breakdown of nicotine, comparable to what would be found in an adult smoker. Overall, about 63 percent of the
CV Sciences is attempting to create a drug that combines CBD and nicotine as a smokeless tobacco-cessation solution. This initial drug candidate is where those lawsuits have originated. You see, back in August, noted short-seller Citron Research released
The proposed menthol cigarettes ban will have to make it through a protracted process for federal regulations, which could take at least two years. But the new restrictions still signal a strong move to regulate nicotine, and if realized are a victory in
great variability in the marketplace today, with some ECIGs delivering little or no nicotine to the user20,21 and others, under certain conditions, yielding higher doses of nicotine in a few puffs than has been observed for an entire single combustible ci
Juul is working to develop a pod with lower nicotine content that will deliver the same “hit” by increasing the voltage in the device. Running at a higher temperature increases nicotine delivery, as well as generation of the other toxic chemicals in e-ci
‘People knowledgeable’ about the new products told The Times it would deliver more vapor with lower nicotine content But the alleged new pod might just intensify nicotine delivery and help the company sidestep ever-tightening regulations in the US and E
‘People knowledgeable’ about the new products told The Times it would deliver more vapor with lower nicotine content But the alleged new pod might just intensify nicotine delivery and help the company sidestep ever-tightening regulations in the US and E
even though Gottlieb is a former fellow at the American Enterprise Institute who was appointed by Donald Trump with the expectation that he would champion deregulatory policies, his longer term plans align the FDA with the most strident anti-smoking group
